2m 2m 2m 2m 2m 2m 2m
ABVC BIOPHARMA (ABVC)
NASDAQ
$1.01+$0.03 (+2.64%)
Price as of Sep 11, 2026 7:59 PM EDT- $26.1MMarket Cap
- -65.61%1-Year Change
- BiotechnologyIndustry
ABVC BIOPHARMA (ABVC)
$1.01+$0.03 (+2.64%)
ABVC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.98 | ||
Change | +$0.004 (+0.40%) | ||
Open | $1.01 | ||
High | $1.01 | ||
Low | $0.98 | ||
Previous Close | $0.98 | ||
Volume | 97,687 | ||
30-Day Average Volume | 113,883 | ||
1-Week Change | 2.08% | ||
1-Month Change | -0.50% | ||
1-Year Change | -65.61% | ||
3-Year Change | -8.40% | ||
5-Year Change | -96.95% | ||
Fundamentals | |||
Shares Outstanding | 26.7M | ||
Total Assets | $19.4M | ||
Market Cap | $26.1M | ||
Enterprise Value | $26.5M | ||
Period: QTR TTM FY | |||
Revenue | -$36.00 | ||
Net Income | -$736,934.00 | ||
Free Cash Flow | -$244,413.00 | ||
EBIT | -$736,934.00 | ||
EBITDA | -$730,418.00 | ||
Net Working Capital | -$5.3M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | -735,611 | ||
P/B | 3 | ||
P/E | -33 | ||
PEG | -1 | ||
Price/Free Cash Flow | -107 | ||
Price/Operating Cash Flow | -107 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2023 | ||
Earnings & Revenue